Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD

Chad Moretz,1 Srinivas Annavarapu,1 Rakesh Luthra,2 Seth Goldfarb,1 Andrew Renda,3 Asif Shaikh,2 Shuchita Kaila2 1Comprehensive Health Insights, Louisville, KY, USA; 2Boehringer Ingelheim, Ridgefield, CT, USA; 3Humana Inc., Louisville, KY, USA Background: A claims-based model to predict patients l...

Full description

Bibliographic Details
Main Authors: Moretz C, Annavarapu S, Luthra R, Goldfarb S, Renda A, Shaikh A, Kaila S
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/spirometry-evaluation-to-assess-performance-of-a-claims-based-predicti-peer-reviewed-article-COPD
_version_ 1818982802381602816
author Moretz C
Annavarapu S
Luthra R
Goldfarb S
Renda A
Shaikh A
Kaila S
author_facet Moretz C
Annavarapu S
Luthra R
Goldfarb S
Renda A
Shaikh A
Kaila S
author_sort Moretz C
collection DOAJ
description Chad Moretz,1 Srinivas Annavarapu,1 Rakesh Luthra,2 Seth Goldfarb,1 Andrew Renda,3 Asif Shaikh,2 Shuchita Kaila2 1Comprehensive Health Insights, Louisville, KY, USA; 2Boehringer Ingelheim, Ridgefield, CT, USA; 3Humana Inc., Louisville, KY, USA Background: A claims-based model to predict patients likely to have undiagnosed COPD was developed by Moretz et al in 2015. This study aims to assess the performance of the aforementioned model using prospectively collected spirometry data.Methods: A study population aged 40–89 years enrolled in a Medicare Advantage plan with prescription drug coverage or commercial health plan and without a claim for COPD diagnosis was identified from April 1, 2012 to March 31, 2016 in the Humana claims database. This population was stratified into subjects likely or unlikely to have undiagnosed COPD using the claims-based predictive model. Subjects were randomly selected for spirometry evaluation of FEV1 and FVC. The predictive model was validated using airflow limitation ratio (FEV1/FVC <0.70).Results: A total of 218 subjects classified by the predictive model as likely and 331 not likely to have undiagnosed COPD completed spirometry evaluation. Those predicted to have undiagnosed COPD had a higher mean age (70.2 vs 67.9 years, P=0.0012) and a lower mean FEV1/FVC ratio (0.724 vs 0.753, P=0.0002) compared to those predicted not to have undiagnosed COPD. Performance metrics for the predictive model were: area under the curve =0.61, sensitivity =52.5%, specificity =64.6%, positive predictive value =33.5%, and negative predictive value =80.1%.Conclusion: The claims-based predictive model identifies those not at risk of having COPD eight out of ten times, and those who are likely to have COPD one out of three times. Keywords: COPD, exacerbation, predictive model, clinical validation, prevention
first_indexed 2024-12-20T17:53:00Z
format Article
id doaj.art-2d44e23b8a3143868c90b6f856dff25f
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-20T17:53:00Z
publishDate 2019-02-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-2d44e23b8a3143868c90b6f856dff25f2022-12-21T19:30:48ZengDove Medical PressInternational Journal of COPD1178-20052019-02-01Volume 1443944644117Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPDMoretz CAnnavarapu SLuthra RGoldfarb SRenda AShaikh AKaila SChad Moretz,1 Srinivas Annavarapu,1 Rakesh Luthra,2 Seth Goldfarb,1 Andrew Renda,3 Asif Shaikh,2 Shuchita Kaila2 1Comprehensive Health Insights, Louisville, KY, USA; 2Boehringer Ingelheim, Ridgefield, CT, USA; 3Humana Inc., Louisville, KY, USA Background: A claims-based model to predict patients likely to have undiagnosed COPD was developed by Moretz et al in 2015. This study aims to assess the performance of the aforementioned model using prospectively collected spirometry data.Methods: A study population aged 40–89 years enrolled in a Medicare Advantage plan with prescription drug coverage or commercial health plan and without a claim for COPD diagnosis was identified from April 1, 2012 to March 31, 2016 in the Humana claims database. This population was stratified into subjects likely or unlikely to have undiagnosed COPD using the claims-based predictive model. Subjects were randomly selected for spirometry evaluation of FEV1 and FVC. The predictive model was validated using airflow limitation ratio (FEV1/FVC <0.70).Results: A total of 218 subjects classified by the predictive model as likely and 331 not likely to have undiagnosed COPD completed spirometry evaluation. Those predicted to have undiagnosed COPD had a higher mean age (70.2 vs 67.9 years, P=0.0012) and a lower mean FEV1/FVC ratio (0.724 vs 0.753, P=0.0002) compared to those predicted not to have undiagnosed COPD. Performance metrics for the predictive model were: area under the curve =0.61, sensitivity =52.5%, specificity =64.6%, positive predictive value =33.5%, and negative predictive value =80.1%.Conclusion: The claims-based predictive model identifies those not at risk of having COPD eight out of ten times, and those who are likely to have COPD one out of three times. Keywords: COPD, exacerbation, predictive model, clinical validation, preventionhttps://www.dovepress.com/spirometry-evaluation-to-assess-performance-of-a-claims-based-predicti-peer-reviewed-article-COPDCOPDexacerbationpredictive modelclinical validationprevention
spellingShingle Moretz C
Annavarapu S
Luthra R
Goldfarb S
Renda A
Shaikh A
Kaila S
Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
International Journal of COPD
COPD
exacerbation
predictive model
clinical validation
prevention
title Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
title_full Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
title_fullStr Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
title_full_unstemmed Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
title_short Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD
title_sort spirometry evaluation to assess performance of a claims based predictive model identifying patients with undiagnosed copd
topic COPD
exacerbation
predictive model
clinical validation
prevention
url https://www.dovepress.com/spirometry-evaluation-to-assess-performance-of-a-claims-based-predicti-peer-reviewed-article-COPD
work_keys_str_mv AT moretzc spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd
AT annavarapus spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd
AT luthrar spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd
AT goldfarbs spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd
AT rendaa spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd
AT shaikha spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd
AT kailas spirometryevaluationtoassessperformanceofaclaimsbasedpredictivemodelidentifyingpatientswithundiagnosedcopd